FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311542832> ?p ?o ?g. }

• W4311542832 endingPage "167" @default.
• W4311542832 startingPage "167" @default.
• W4311542832 abstract "Introduction: Anaphylaxis is an acute, systemic allergic reaction that can be fatal if not treated appropriately. Current guidelines recommend epinephrine 0.01 mg/kg for pediatric patients weighing 30 kg or less and a single dose maximum of 0.3 mg to 0.5 mg for adults. Studies have shown that more than 13% of patients presenting to the ED with anaphylaxis required more than one dose of epinephrine to achieve anaphylaxis resolution. No study to date has compared 0.3 mg and 0.5 mg epinephrine as an initial dose in preventing progression of recurrent symptoms or protracted anaphylaxis. We hypothesize that an initial dose of 0.5 mg of epinephrine when compared to 0.3 mg will lead to reduced redosing of epinephrine for anaphylaxis resolution. Methods: This is a single-center, retrospective, observational study of patients who presented to the UC Davis Medical Center emergency department and received an initial dose of 0.3 or 0.5 mg of epinephrine for treatment of anaphylaxis from January 2010 to January 2022. The primary endpoint is the frequency of redosing epinephrine to achieve resolution of anaphylaxis using 0.3 mg or 0.5 mg epinephrine as an initial dose. Secondary endpoints include the number of patients requiring hospital admission, the number of patients who required epinephrine infusion, incorrect administrations of epinephrine, and the average total milligrams of epinephrine used. Results: 187 patients met the inclusion criteria of anaphylaxis. Of patients receiving 0.3 mg of epinephrine as an initial dose, 34/97 (35%) patients required redosing while 6/69 (9%) of patients receiving 0.5 mg required redosing. Patients were significantly more likely to be redosed when receiving an initial dose of 0.3 mg (p < 0.001). Of the 187 patients, 36 required hospital admissions with 7 requiring epinephrine infusions. There were no incorrect administrations of epinephrine reported. The average total milligrams of epinephrine used was 0.5 mg. Conclusions: This study identified that 26% more patients required redosing when using 0.3 mg compared to 0.5 mg of epinephrine as initial dose. This highlights opportunities for change in current standards of care when it comes to initial management of anaphylaxis in the emergency department." @default.
• W4311542832 created "2022-12-27" @default.
• W4311542832 creator A5033891122 @default.
• W4311542832 creator A5045605838 @default.
• W4311542832 creator A5052256800 @default.
• W4311542832 creator A5054998656 @default.
• W4311542832 date "2022-12-15" @default.
• W4311542832 modified "2023-09-30" @default.
• W4311542832 title "363: COMPARING EPINEPHRINE 0.3 MG AND 0.5 MG AS AN INITIAL DOSE IN COMPLETE RESOLUTION OF ANAPHYLAXIS" @default.
• W4311542832 doi "https://doi.org/10.1097/01.ccm.0000907180.54070.5f" @default.
• W4311542832 hasPublicationYear "2022" @default.
• W4311542832 type Work @default.
• W4311542832 citedByCount "0" @default.
• W4311542832 crossrefType "journal-article" @default.
• W4311542832 hasAuthorship W4311542832A5033891122 @default.
• W4311542832 hasAuthorship W4311542832A5045605838 @default.
• W4311542832 hasAuthorship W4311542832A5052256800 @default.
• W4311542832 hasAuthorship W4311542832A5054998656 @default.
• W4311542832 hasBestOaLocation W43115428321 @default.
• W4311542832 hasConcept C118552586 @default.
• W4311542832 hasConcept C126322002 @default.
• W4311542832 hasConcept C168563851 @default.
• W4311542832 hasConcept C203014093 @default.
• W4311542832 hasConcept C203092338 @default.
• W4311542832 hasConcept C207480886 @default.
• W4311542832 hasConcept C2775859304 @default.
• W4311542832 hasConcept C2775933838 @default.
• W4311542832 hasConcept C2780724011 @default.
• W4311542832 hasConcept C42219234 @default.
• W4311542832 hasConcept C71924100 @default.
• W4311542832 hasConceptScore W4311542832C118552586 @default.
• W4311542832 hasConceptScore W4311542832C126322002 @default.
• W4311542832 hasConceptScore W4311542832C168563851 @default.
• W4311542832 hasConceptScore W4311542832C203014093 @default.
• W4311542832 hasConceptScore W4311542832C203092338 @default.
• W4311542832 hasConceptScore W4311542832C207480886 @default.
• W4311542832 hasConceptScore W4311542832C2775859304 @default.
• W4311542832 hasConceptScore W4311542832C2775933838 @default.
• W4311542832 hasConceptScore W4311542832C2780724011 @default.
• W4311542832 hasConceptScore W4311542832C42219234 @default.
• W4311542832 hasConceptScore W4311542832C71924100 @default.
• W4311542832 hasIssue "1" @default.
• W4311542832 hasLocation W43115428321 @default.
• W4311542832 hasLocation W43115428322 @default.
• W4311542832 hasOpenAccess W4311542832 @default.
• W4311542832 hasPrimaryLocation W43115428321 @default.
• W4311542832 hasRelatedWork W2047833849 @default.
• W4311542832 hasRelatedWork W2048038167 @default.
• W4311542832 hasRelatedWork W2098582444 @default.
• W4311542832 hasRelatedWork W2893872506 @default.
• W4311542832 hasRelatedWork W2996579740 @default.
• W4311542832 hasRelatedWork W3005698903 @default.
• W4311542832 hasRelatedWork W4210411220 @default.
• W4311542832 hasRelatedWork W4288712534 @default.
• W4311542832 hasRelatedWork W4361001364 @default.
• W4311542832 hasRelatedWork W157759501 @default.
• W4311542832 hasVolume "51" @default.
• W4311542832 isParatext "false" @default.
• W4311542832 isRetracted "false" @default.
• W4311542832 workType "article" @default.